These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14714398)

  • 1. Liposomal cytokines and liposomes targeted to costimulatory molecules as adjuvants for human immunodeficiency virus subunit vaccines.
    Ozpolat B; Lachman LB
    Methods Enzymol; 2003; 373():92-100. PubMed ID: 14714398
    [No Abstract]   [Full Text] [Related]  

  • 2. Archaeobacterial ether lipid liposomes as vaccine adjuvants.
    Sprott GD; Patel GB; Krishnan L
    Methods Enzymol; 2003; 373():155-72. PubMed ID: 14714403
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies for optimizing targeting and delivery of mucosal HIV vaccines.
    Ahlers JD; Belyakov IM
    Eur J Immunol; 2009 Oct; 39(10):2657-69. PubMed ID: 19609978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel adjuvants and delivery systems for HIV vaccines.
    O'Hagan DT; Lavelle E
    AIDS; 2002; 16 Suppl 4():S115-24. PubMed ID: 12699008
    [No Abstract]   [Full Text] [Related]  

  • 5. pH-sensitive liposomes as adjuvants for peptide antigens.
    Chang JS; Choi MJ
    Methods Enzymol; 2003; 373():127-36. PubMed ID: 14714401
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of intranasal with targeted lymph node immunization using PR8-Flu ISCOM adjuvanted HIV antigens in macaques.
    Koopman G; Bogers WM; van Gils M; Koornstra W; Barnett S; Morein B; Lehner T; Heeney JL
    J Med Virol; 2007 May; 79(5):474-82. PubMed ID: 17385685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines as adjuvants for improving anti-HIV responses.
    Morrow MP; Weiner DB
    AIDS; 2008 Jan; 22(3):333-8. PubMed ID: 18195559
    [No Abstract]   [Full Text] [Related]  

  • 8. Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines.
    Steers NJ; Peachman KK; McClain S; Alving CR; Rao M
    Vaccine; 2009 Nov; 27(49):6939-49. PubMed ID: 19748578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoliposomes containing antibodies to costimulatory molecules as adjuvants for HIV subunit vaccines.
    Ozpolat B; Rao XM; Powell MF; Lachman LB
    AIDS Res Hum Retroviruses; 1998 Mar; 14(5):409-17. PubMed ID: 9546800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical hypothesis: Application of AIDS vaccines together with thyroid hormones to increase their immunogenic effect.
    Halabe Bucay A
    Vaccine; 2007 Aug; 25(33):6292-3. PubMed ID: 17570565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
    Bower JF; Green TD; Ross TM
    Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120.
    Wang X; Uto T; Akagi T; Akashi M; Baba M
    J Virol; 2007 Sep; 81(18):10009-16. PubMed ID: 17609261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A need for effective adjuvants.
    Bunce CJ; Morse MA
    Curr Opin Mol Ther; 2003 Feb; 5(1):8-9. PubMed ID: 12669464
    [No Abstract]   [Full Text] [Related]  

  • 14. CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.
    Jiang JQ; Patrick A; Moss RB; Rosenthal KL
    J Virol; 2005 Jan; 79(1):393-400. PubMed ID: 15596832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine-containing liposomes as adjuvants for subunit vaccines.
    Lachman LB; Shih LC; Rao XM; Ullrich SE; Cleland JL
    Pharm Biotechnol; 1995; 6():659-71. PubMed ID: 7551242
    [No Abstract]   [Full Text] [Related]  

  • 17. The utility of ISCOMATRIX adjuvant for dose reduction of antigen for vaccines requiring antibody responses.
    Boyle J; Eastman D; Millar C; Camuglia S; Cox J; Pearse M; Good J; Drane D
    Vaccine; 2007 Mar; 25(14):2541-4. PubMed ID: 17240491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-containing liposomes as adjuvants for HIV subunit vaccines.
    Lachman LB; Shih LC; Rao XM; Hu X; Bucana CD; Ullrich SE; Cleland JL
    AIDS Res Hum Retroviruses; 1995 Aug; 11(8):921-32. PubMed ID: 7492439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic liposomes as vaccine adjuvants.
    Christensen D; Korsholm KS; Andersen P; Agger EM
    Expert Rev Vaccines; 2011 Apr; 10(4):513-21. PubMed ID: 21506648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
    Wang X; Uto T; Akagi T; Akashi M; Baba M
    J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.